Abiopharma

🔍 Ho Emily (Executive)

Company: Snowflake Inc. (SNOW)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 268 shares of Common Stock at $175.4 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 43,204.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 497 shares of Common Stock at $175.4 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 42,707.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 3,987 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 46,694.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 2,141 shares of Common Stock at $173.968 per share (Direct)
  Date: 2026-03-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,553.00 | transaction_form_type: 4 | Footnotes: F4, F2

Footnotes:

• F1: Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.
• F2: Includes shares to be issued in connection with the vesting of one or more restricted stock units.
• F3: The shares represent restricted stock units, which will vest quarterly over four years with 6.25% vesting on June 15, 2026 and on each Quarterly Vest Date thereafter, subject to the Reporting Person's continuous service through each such vesting date. Quarterly Vest Dates are each of March 15, June 15, September 15, and December 15.
• F4: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $173.920 to $174.040, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.